| Medical and Health Sciences | Lifetime | 714 | DE 29 | 99.97 |
| Biological Sciences | Lifetime | 583 | DE 32 | 99.93 |
| Pathology and Forensic Medicine | Lifetime | 74 | DE 5 | 99.70 |
| Cancer Research | Lifetime | 74 | DE 4 | 99.62 |
| Genetics | Lifetime | 170 | DE 3 | 99.64 |
| Oncology | Lifetime | 172 | DE 6 | 99.71 |
| Molecular Biology | Lifetime | 574 | DE 35 | 99.72 |
| Epidemiology | Lifetime | 445 | DE 23 | 99.44 |
| Pulmonary and Respiratory Medicine | Lifetime | 750 | DE 37 | 98.87 |
| Public, Environmental and Occupational Health | Lifetime | 981 | DE 21 | 98.58 |
| Health, Toxicology and Mutagenesis | Lifetime | 432 | DE 23 | 98.25 |
| Pediatrics, Perinatology and Child Health | Lifetime | 920 | DE 20 | 96.82 |
| Medical Genetics | Lifetime | 404 | DE 47 | 96.53 |
| Reproductive Medicine | Lifetime | 703 | DE 16 | 92.85 |
| Hematology | Lifetime | 778 | DE 54 | 92.86 |
| Otolaryngology | Lifetime | 503 | DE 20 | 88.30 |
| Oncology | 2021-2025 | 366 | DE 22 | 96.02 |
| Surgery | 2021-2025 | 731 | DE 32 | 93.61 |
| Epidemiology | 2021-2025 | 832 | DE 31 | 91.75 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 639 | DE 29 | 92.32 |
| Pathology and Forensic Medicine | 2021-2025 | 300 | DE 19 | 90.34 |
| Cancer Research | 2021-2025 | 303 | DE 18 | 82.39 |
| Cancer Diagnosis and Treatment | Lifetime | 14 | DE 2 | 99.82 |
| Carcinogens and Genotoxicity Assessment | Lifetime | 17 | DE 2 | 99.79 |
| Multiple and Secondary Primary Cancers | Lifetime | 9 | DE 2 | 99.78 |
| Genetic factors in colorectal cancer | Lifetime | 42 | DE 3 | 99.76 |
| BRCA gene mutations in cancer | Lifetime | 25 | DE 1 | 99.60 |
| Global Cancer Incidence and Screening | Lifetime | 45 | DE 2 | 99.56 |
| DNA Repair Mechanisms | Lifetime | 109 | DE 2 | 99.24 |
| Epigenetics and DNA Methylation | Lifetime | 283 | DE 21 | 99.17 |
| Effects and risks of endocrine disrupting chemicals | Lifetime | 87 | DE 3 | 99.29 |
| Lymphoma Diagnosis and Treatment | Lifetime | 214 | DE 18 | 99.31 |
| Cancer Genomics and Diagnostics | Lifetime | 306 | DE 15 | 99.40 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 262 | DE 28 | 99.20 |
| Tumors and Oncological Cases | Lifetime | 89 | DE 6 | 98.84 |
| Colorectal Cancer Screening and Detection | Lifetime | 268 | DE 9 | 98.87 |
| Acute Lymphoblastic Leukemia research | Lifetime | 264 | DE 30 | 98.94 |
| DNA and Nucleic Acid Chemistry | Lifetime | 303 | DE 16 | 98.68 |
| Ovarian cancer diagnosis and treatment | Lifetime | 284 | DE 9 | 98.69 |
| Cancer Risks and Factors | Lifetime | 137 | DE 7 | 98.95 |
| Cancer-related Molecular Pathways | Lifetime | 366 | DE 11 | 98.69 |
| Cancer-related molecular mechanisms research | Lifetime | 708 | DE 29 | 98.03 |
| Nutrition, Genetics, and Disease | Lifetime | 174 | DE 9 | 97.55 |
| Cutaneous Melanoma Detection and Management | Lifetime | 207 | DE 16 | 98.42 |
| Cervical Cancer and HPV Research | Lifetime | 396 | DE 16 | 98.13 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 473 | DE 19 | 98.13 |
| Multiple Myeloma Research and Treatments | Lifetime | 365 | DE 20 | 97.91 |
| Childhood Cancer Survivors' Quality of Life | Lifetime | 469 | DE 21 | 97.80 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 443 | DE 36 | 98.21 |
| Occupational and environmental lung diseases | Lifetime | 193 | DE 6 | 97.72 |
| Head and Neck Cancer Studies | Lifetime | 539 | DE 16 | 97.99 |
| Diabetes and associated disorders | Lifetime | 711 | DE 35 | 97.47 |
| Neuroendocrine Tumor Research Advances | Lifetime | 783 | DE 58 | 97.55 |
| Genomics and Chromatin Dynamics | Lifetime | 780 | DE 57 | 97.01 |
| Glutathione Transferases and Polymorphisms | Lifetime | 202 | DE 20 | 96.67 |
| Nonmelanoma Skin Cancer Studies | Lifetime | 327 | DE 33 | 96.72 |
| Testicular diseases and treatments | Lifetime | 331 | DE 25 | 96.55 |
| Toxic Organic Pollutants Impact | Lifetime | 792 | DE 40 | 97.09 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 414 | DE 15 | 95.53 |
| Molecular Biology Techniques and Applications | Lifetime | 901 | DE 74 | 94.74 |
| Genetic Associations and Epidemiology | Lifetime | 793 | DE 33 | 96.20 |
| Family Support in Illness | Lifetime | 566 | DE 22 | 95.10 |
| Melanoma and MAPK Pathways | Lifetime | 499 | DE 40 | 95.21 |
| Genomics and Rare Diseases | Lifetime | 936 | DE 51 | 94.04 |
| Digestive system and related health | Lifetime | 988 | DE 50 | 92.68 |
| Skin Protection and Aging | Lifetime | 875 | DE 84 | 93.57 |
| Chemical Safety and Risk Management | Lifetime | 161 | DE 4 | 91.28 |
| Celiac Disease Research and Management | Lifetime | 745 | DE 34 | 92.15 |
| Safe Handling of Antineoplastic Drugs | Lifetime | 136 | DE 9 | 87.98 |
| Occupational exposure and asthma | Lifetime | 823 | DE 59 | 89.88 |
| Male Breast Health Studies | Lifetime | 171 | DE 7 | 84.12 |
| Genetically Modified Organisms Research | Lifetime | 827 | DE 45 | 85.06 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 17 | DE 1 | 97.21 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 197 | DE 8 | 96.40 |
| Global Cancer Incidence and Screening | 2021-2025 | 175 | DE 4 | 96.38 |
| Genetic factors in colorectal cancer | 2021-2025 | 217 | DE 9 | 95.30 |
| BRCA gene mutations in cancer | 2021-2025 | 437 | DE 15 | 89.42 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 709 | DE 38 | 90.33 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 670 | DE 44 | 91.26 |
| Protein Degradation and Inhibitors | 2021-2025 | 653 | DE 42 | 88.36 |
| Urinary and Genital Oncology Studies | 2021-2025 | 999 | DE 78 | 79.69 |
| Carcinogens and Genotoxicity Assessment | 2021-2025 | 934 | DE 67 | 61.38 |